Johnson Chemical Pharmaceutical Works Co Ltd
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, card… Read more
Johnson Chemical Pharmaceutical Works Co Ltd (4747) - Total Liabilities
Latest total liabilities as of September 2025: NT$279.70 Million TWD
Based on the latest financial reports, Johnson Chemical Pharmaceutical Works Co Ltd (4747) has total liabilities worth NT$279.70 Million TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Johnson Chemical Pharmaceutical Works Co Ltd - Total Liabilities Trend (2009–2024)
This chart illustrates how Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Johnson Chemical Pharmaceutical Works Co Ltd Competitors by Total Liabilities
The table below lists competitors of Johnson Chemical Pharmaceutical Works Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PS Tec. Co. Ltd
KQ:002230
|
Korea | ₩38.95 Billion |
|
Alpha Lithium Corporation
OTCQX:ALLIF
|
USA | $3.78 Million |
|
Q.S.I Co. LTD
KQ:066310
|
Korea | ₩4.82 Billion |
|
Finger Inc.
KQ:163730
|
Korea | ₩21.07 Billion |
|
Mukand Limited
NSE:MUKANDLTD
|
India | ₹28.18 Billion |
|
Sungchang Hold
KO:000180
|
Korea | ₩140.99 Billion |
|
Naturel Yenilenebilir Enerji Ticare
IS:NATEN
|
Turkey | TL8.02 Billion |
|
Qualicorp Consultoria e Corretora de Seguros S.A
SA:QUAL3
|
Brazil | R$2.63 Billion |
Liability Composition Analysis (2009–2024)
This chart breaks down Johnson Chemical Pharmaceutical Works Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Johnson Chemical Pharmaceutical Works Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Johnson Chemical Pharmaceutical Works Co Ltd (2009–2024)
The table below shows the annual total liabilities of Johnson Chemical Pharmaceutical Works Co Ltd from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$261.36 Million | -18.58% |
| 2023-12-31 | NT$320.99 Million | +91.56% |
| 2022-12-31 | NT$167.56 Million | -6.34% |
| 2021-12-31 | NT$178.91 Million | -25.55% |
| 2020-12-31 | NT$240.33 Million | +131.54% |
| 2019-12-31 | NT$103.79 Million | +3.49% |
| 2018-12-31 | NT$100.29 Million | +4.87% |
| 2017-12-31 | NT$95.64 Million | -22.30% |
| 2016-12-31 | NT$123.09 Million | +28.26% |
| 2015-12-31 | NT$95.97 Million | -17.97% |
| 2014-12-31 | NT$117.00 Million | +16.92% |
| 2013-12-31 | NT$100.06 Million | +47.30% |
| 2012-12-31 | NT$67.93 Million | -23.07% |
| 2011-12-31 | NT$88.30 Million | +22.53% |
| 2010-12-31 | NT$72.06 Million | +25.94% |
| 2009-12-31 | NT$57.22 Million | -- |